George D Dangas

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. doi request reprint Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial
    George D Dangas
    Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    EuroIntervention 8:1033-9. 2013
  2. pmc Facilitated/pharmaco-invasive approaches in STEMI
    Davide Capodanno
    Ferrarotto Hospital, University of Catania, Catania, Italy
    Curr Cardiol Rev 8:177-80. 2012
  3. doi request reprint Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes
    George D Dangas
    Department of Cardiology, Mount Sinai Medical Center, New York, NY 10029, USA
    JACC Cardiovasc Interv 5:1097-105. 2012
  4. doi request reprint Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial
    George D Dangas
    Department of Cardiology, Mount Sinai Medical Center, New York, New York 10029, USA
    J Am Coll Cardiol 59:1752-9. 2012
  5. doi request reprint Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis
    George D Dangas
    Mount Sinai Medical Center, New York, NY, USA
    J Am Coll Cardiol 57:2309-16. 2011
  6. doi request reprint In-stent restenosis in the drug-eluting stent era
    George D Dangas
    Cardiovascular Institute, Mount Sinai Medical Center, New York, New York 10029, USA
    J Am Coll Cardiol 56:1897-907. 2010
  7. doi request reprint Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction
    George D Dangas
    Cardiovascular Institute, Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    Circulation 123:1745-56. 2011
  8. ncbi request reprint Endovascular treatment of infrarenal aortic stenosis: importance of multimodality imaging
    George D Dangas
    Cardiovascular Institute, Mount Sinai Medical Center, New York, NY 10029 USA
    J Invasive Cardiol 23:E192-6. 2011
  9. doi request reprint A risk score to predict bleeding in patients with acute coronary syndromes
    Roxana Mehran
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
    J Am Coll Cardiol 55:2556-66. 2010
  10. doi request reprint Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 54:1293-302. 2009

Detail Information

Publications83

  1. doi request reprint Stent thrombosis after primary angioplasty for STEMI in relation to non-adherence to dual antiplatelet therapy over time: results of the HORIZONS-AMI trial
    George D Dangas
    Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    EuroIntervention 8:1033-9. 2013
    ..Rates of stent thrombosis (ST) after ST-elevation myocardial infarction (STEMI) may vary over time and the relationship of this complication with non-adherence to dual antiplatelet therapy (DAPT) during long-term follow-up remains unclear...
  2. pmc Facilitated/pharmaco-invasive approaches in STEMI
    Davide Capodanno
    Ferrarotto Hospital, University of Catania, Catania, Italy
    Curr Cardiol Rev 8:177-80. 2012
    ..Conversely, a role for pharmacoinvasive recanalization, defined as pharmacological reperfusion followed by rapid transfer for routine delayed coronary angiography and PCI may still be considered in centers without on-site PCI capability...
  3. doi request reprint Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes
    George D Dangas
    Department of Cardiology, Mount Sinai Medical Center, New York, NY 10029, USA
    JACC Cardiovasc Interv 5:1097-105. 2012
    ..This study sought to develop a practical risk score to predict the risk of stent thrombosis (ST) after percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS)...
  4. doi request reprint Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial
    George D Dangas
    Department of Cardiology, Mount Sinai Medical Center, New York, New York 10029, USA
    J Am Coll Cardiol 59:1752-9. 2012
    ....
  5. doi request reprint Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis
    George D Dangas
    Mount Sinai Medical Center, New York, NY, USA
    J Am Coll Cardiol 57:2309-16. 2011
    ..We investigated the outcomes of switching to bivalirudin after initial administration of heparin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention...
  6. doi request reprint In-stent restenosis in the drug-eluting stent era
    George D Dangas
    Cardiovascular Institute, Mount Sinai Medical Center, New York, New York 10029, USA
    J Am Coll Cardiol 56:1897-907. 2010
    ..Intravascular imaging can assist in defining the mechanism and selecting treatment modalities. Based upon the current available evidence, an algorithm for the treatment approaches to DES restenosis is proposed...
  7. doi request reprint Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction
    George D Dangas
    Cardiovascular Institute, Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    Circulation 123:1745-56. 2011
    ..Concerns persist regarding the risk of stent thrombosis in the setting of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction...
  8. ncbi request reprint Endovascular treatment of infrarenal aortic stenosis: importance of multimodality imaging
    George D Dangas
    Cardiovascular Institute, Mount Sinai Medical Center, New York, NY 10029 USA
    J Invasive Cardiol 23:E192-6. 2011
    ..Improved non-invasive and intravascular imaging can guide with great accuracy infrarenal aortic stenosis procedures and may enable the use of reduced-size access sheaths and devices in fragile patients with vasculopathies...
  9. doi request reprint A risk score to predict bleeding in patients with acute coronary syndromes
    Roxana Mehran
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
    J Am Coll Cardiol 55:2556-66. 2010
    ..The aim of this study was to develop a practical risk score to predict the risk and implications of major bleeding in acute coronary syndromes (ACS)...
  10. doi request reprint Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 54:1293-302. 2009
    ..We assessed the incidence, predictors, and outcomes of gastrointestinal bleeding (GIB) in patients with acute coronary syndromes (ACS)...
  11. doi request reprint Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial In
    Adam J Saltzman
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    JACC Cardiovasc Interv 4:1011-9. 2011
    ..This study sought to investigate the impact of chronic kidney disease (CKD) in patients undergoing percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) with different antithrombotic strategies...
  12. doi request reprint Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials
    Jennifer Yu
    Mount Sinai Medical Center, Cardiovascular Institute, New York, New York
    Catheter Cardiovasc Interv 87:391-400. 2016
    ..We aimed to construct a predictive model for one-year mortality in patients undergoing invasive coronary evaluation and to examine the impact of bivalirudin on survival according to the level of baseline risk...
  13. doi request reprint Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent int
    Roxana Mehran
    Department of Cardiology, Mount Sinai Medical Center, New York, New York, USA
    JACC Cardiovasc Interv 4:654-64. 2011
    ..This study sought to develop a risk score predictive of bleeding in patients undergoing percutaneous coronary intervention (PCI) and to investigate the impact of bleeding on subsequent mortality...
  14. doi request reprint Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis
    Young Hak Kim
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 101:801-6. 2008
    ..However, bifurcation stenosis remains a significant predictor of unfavorable clinical outcome...
  15. doi request reprint Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY)
    Roxana Mehran
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
    JACC Cardiovasc Interv 2:748-57. 2009
    ....
  16. ncbi request reprint Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)
    Yoshihiro Tsuchiya
    The Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 98:464-9. 2006
    ..The EES appears to be effective for treatment of de novo coronary lesions in decreasing neointimal proliferation at 6-month follow-up compared with BMSs, regardless of vessel size...
  17. doi request reprint Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents
    Bimmer E Claessen
    Cardiovascular Research Foundation, Clinical Trial Center, New York, New York, USA
    JACC Cardiovasc Interv 4:974-81. 2011
    ..This study sought to assess the impact of intravascular ultrasound (IVUS)-guided versus angiography-guided drug-eluting stent (DES) implantation...
  18. doi request reprint Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation
    Xuebo Liu
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    JACC Cardiovasc Interv 2:997-1004. 2009
    ..We used intravascular ultrasound (IVUS) to assess incidence, predictors, morphology, and angiographic findings of edge dissections after drug-eluting stent (DES) implantation...
  19. doi request reprint Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
    Roxana Mehran
    Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
    Lancet 374:1149-59. 2009
    ..Here, we assess whether these initial benefits were maintained at 1 year of follow-up...
  20. doi request reprint Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized Trials
    George D Dangas
    From the Division of Cardiology, Mount Sinai Medical Center, New York, NY G D D, M M S, R M Clinical Trials Center, Cardiovascular Research Foundation, New York, NY G D D, R M, G W S Department of Cardiology, Rigshospitalet, Copenhagen, Denmark M M S, P C French Alliance for Cardiovascular Trials, Département Hospitalo Universitaire Fibrosis, Inflammation, Remodelling, Universite Paris Diderot, Paris, France P G S INSERM U 1148, Paris, France P G S Department of Cardiology, Hopital Bichat, Paris, France P G S National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, United Kingdom P G S Department of Medicine, Nykoebing Falster Hospital, Denmark P C Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands A v H The Medicines Company, Parsippany, NJ J P, D B, E N D Division of Cardiology
    Circ Cardiovasc Interv 9:e003272. 2016
    ..We sought to determine the predictors of and risk of mortality after early ST according to procedural antithrombotic therapy...
  21. ncbi request reprint Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis
    Koichi Sano
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, USA
    Am J Cardiol 98:1559-62. 2006
    ....
  22. doi request reprint Long-term outcome of percutaneous coronary intervention for chronic total occlusions
    Roxana Mehran
    Mount Sinai Medical Center and the Cardiovascular Research Foundation, New York, New York 10029, USA
    JACC Cardiovasc Interv 4:952-61. 2011
    ..The aim of this study was to evaluate long-term clinical outcomes after percutaneous coronary intervention (PCI) for chronic total occlusions (CTO)...
  23. doi request reprint One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study
    Gennaro Giustino
    Mount Sinai Medical Center, New York, New York
    Catheter Cardiovasc Interv 87:703-9. 2016
    ..Long-term clinical outcomes after exposure to non-ionic iso-osmolar contrast medium (IOCM) or ionic low-osmolar CM (LOCM) in patients with chronic kidney disease (CKD) undergoing coronary angiography are unclear...
  24. doi request reprint Impact of target vessel on long-term survival after percutaneous coronary intervention for chronic total occlusions
    Bimmer E Claessen
    Cardiovascular Research Foundation, New York, New York 10029, USA
    Catheter Cardiovasc Interv 82:76-82. 2013
    ..This study sought to investigate whether there is a differential prognostic effect of successful percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) according to the target vessel the CTO is located in...
  25. ncbi request reprint Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial
    Marco G Mennuni
    Icahn School of Medicine at Mount Sinai, One Gustave L Levy Place, Box 1030, New York, NY 10029 USA
    J Invasive Cardiol 27:468-73. 2015
    ..The aim of this study was to compare the outcomes of ACS patients with pLAD culprit lesions receiving percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG)...
  26. ncbi request reprint Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention
    Eugenia Nikolsky
    Cardiovascular Research Foundation, and Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 94:300-5. 2004
    ..Contrast-induced nephropathy was among the independent predictors of a 1-year mortality rate (OR 2.75, p <0.001)...
  27. ncbi request reprint Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings
    Jiro Aoki
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY, USA
    Am J Cardiol 101:58-62. 2008
    ..In conclusion, the incidence of DES and BMS overlap stenting is rare in daily practice, but this procedure is associated with a high rate of target vessel revascularization...
  28. pmc High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study
    Amala P Chirumamilla
    Albert Einstein College of Medicine, New York, New York, USA
    JACC Cardiovasc Imaging 5:540-9. 2012
    ..This study sought to evaluate the relationship between platelet reactivity and atherosclerotic burden in patients undergoing percutaneous coronary intervention (PCI) with pre-intervention volumetric intravascular ultrasound (IVUS) imaging...
  29. ncbi request reprint Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation
    Hideo Takebayashi
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 95:498-502. 2005
    ....
  30. ncbi request reprint A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique"
    Issam Moussa
    Cardiovascular Research Foundation and New York Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 97:1317-21. 2006
    ..Nonetheless, despite the excellent patency rates of the main vessel, the need for revascularization at the ostium of the side branch was not fully eliminated...
  31. doi request reprint Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) t
    Jennifer Yu
    Zena and Michael A Weiner Cardiovascular Institute, Mount Sinai Medical Center, New York, New York 10029, USA
    JACC Cardiovasc Interv 5:1231-8. 2012
    ....
  32. doi request reprint Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture
    Hiroshi Doi
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, NY, USA
    Am J Cardiol 103:818-23. 2009
    ..03). In conclusion, IVUS is helpful to identify stent fracture as a cause of stent failure and to understand possible mechanisms of stent fracture such as aneurysm formation...
  33. doi request reprint Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery
    Kenichi Tsujita
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 102:1608-13. 2008
    ..IVUS-detectable MBs were observed in approximately 1/4 of patients undergoing LAD imaging at our center...
  34. doi request reprint Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial
    Adriano Caixeta
    Cardiovascular Research Foundation, New York, NY, USA
    Am Heart J 161:298-306.e1. 2011
    ..The aim of the study was to investigate the incidence and clinical consequences of acquired thrombocytopenia in patients with acute coronary syndromes (ACS) in the ACUITY trial...
  35. ncbi request reprint Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis
    Ricardo A Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    J Am Coll Cardiol 46:599-605. 2005
    ..We report intravascular ultrasound (IVUS) findings after crush-stenting of bifurcation lesions...
  36. doi request reprint Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial)
    Harsimran S Singh
    Columbia University Medical Center, New York, New York
    Am J Cardiol 110:940-7. 2012
    ..05, 95% CI 0.78 to 1.41, p = 0.75). The propensity-matched groups also had similar outcomes. In conclusion, abciximab and eptifibatide have comparable bleeding risks and clinical efficacy in primary percutaneous coronary intervention...
  37. ncbi request reprint Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Am J Cardiol 93:1536-9. 2004
    ..These 2 conditions are associated with adverse in-hospital and 1-year outcomes and independently predict early and 1-year mortality...
  38. ncbi request reprint Short- and long-term results after multivessel stenting in diabetic patients
    Roxana Mehran
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 43:1348-54. 2004
    ..The present study evaluated clinical outcomes in diabetic patients after multivessel stenting...
  39. doi request reprint Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial)
    Adriano Caixeta
    Hospital Israelita Albert Einstein, Sao Paulo, Sao Paulo, Brazil Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
    Am J Cardiol 113:203-10. 2014
    ..02 to 1.07; p = 0.002). In the overall study cohort, the SS was an independent predictor of MACE and death, and MVD (vs SVD) was not. In conclusion, the SS is a useful angiographic predictive tool for patients with SVD and MVD...
  40. doi request reprint Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction
    LeRoy E Rabbani
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, New York 10032, USA
    J Interv Cardiol 22:378-84. 2009
    ....
  41. ncbi request reprint Gender differences in long-term clinical outcomes after percutaneous coronary intervention of chronic total occlusions
    Bimmer E Claessen
    Cardiovascular Institute, Mount Sinai Medical Center, One Gustav L Levy Place, Box 1030, New York, NY 10029, USA
    J Invasive Cardiol 24:484-8. 2012
    ..Little is known about gender differences among patients undergoing percutaneous coronary intervention (PCI) for chronic total occlusion (CTO)...
  42. doi request reprint Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry)
    Bimmer E Claessen
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 107:528-34. 2011
    ..In conclusion, use of SESs in unselected patients with coronary artery disease was associated with a low TVF rate at 2 years with an acceptable incidence of stent thrombosis...
  43. doi request reprint A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis
    Xuebo Liu
    Columbia University Medical Center, New York, New York, USA
    JACC Cardiovasc Interv 2:428-34. 2009
    ..We compared intravascular ultrasound findings of drug-eluting stent (DES)-treated lesions that developed thrombosis versus in-stent restenosis (ISR)...
  44. doi request reprint Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy
    Bimmer E Claessen
    Cardiovascular Research Foundation, New York, NY, USA
    J Thromb Thrombolysis 34:165-79. 2012
    ..Additional studies to confirm and validate the utility of these biomarkers are warranted...
  45. doi request reprint Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy
    So Yeon Choi
    Columbia University Medical Center, New York, NY, USA
    Circ Cardiovasc Interv 4:239-47. 2011
    ..IVUS predictors of early ST in patients with acute myocardial infarction have not been studied...
  46. doi request reprint Impact of myocardial bridge on clinical outcome after coronary stent placement
    Kenichi Tsujita
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 103:1344-8. 2009
    ..In conclusion, inadvertent MB stent placement in left anterior descending artery lesions occurred commonly and may have been associated with an increased incidence of late events...
  47. doi request reprint Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
    Gennaro Giustino
    Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine at Mount Sinai, New York, New York Clinical Trials Center, Cardiovascular Research Foundation, New York, New York
    Am J Cardiol 117:1703-13. 2016
    ..Alongside PRU, PCs could be a simple hematological parameter to consider for risk stratification and in tailoring duration and potency of pharmacologic platelet inhibition after DES implantation. ..
  48. doi request reprint Resistant in-stent restenosis in the drug eluting stent era
    Kleanthis Theodoropoulos
    Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai, New York, New York
    Catheter Cardiovasc Interv 88:777-785. 2016
    ..We aim to describe what we propose as the occurrence of "resistant"-ISR (R-ISR) in the DES era, including angiographic patterns and outcomes...
  49. doi request reprint Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization: From the WIN-DES Collaborative Patient-Level Pooled Analysis
    Gennaro Giustino
    The Zena and Michael A Wiener Cardiovascular Institute, Interventional Cardiovascular Research and Clinical Trials Center, Icahn School of Medicine at Mount Sinai, New York, New York
    JACC Cardiovasc Interv 9:674-84. 2016
    ..The purpose of this study was to investigate the safety and efficacy of new-generation drug-eluting stents (DES) versus early-generation DES in women undergoing complex percutaneous coronary intervention (CPCI)...
  50. ncbi request reprint Comparison of provisional 1-stent and 2-stent strategies in diabetic patients with true bifurcation lesions: the EES bifurcation study
    Omar A Meelu
    Mount Sinai School of Medicine, New York, New York
    J Invasive Cardiol 26:619-23. 2014
    ..It is unknown whether use of newer everolimus-eluting stent (EES) implantation impacts relative outcomes of 1-stent and 2-stent strategies in patients with diabetes...
  51. doi request reprint Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of P
    George D Dangas
    Division of Cardiology, Mount Sinai Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York Electronic address
    JACC Cardiovasc Interv 6:914-22. 2013
    ..This study sought to investigate whether the everolimus-eluting stent (EES) is superior to the paclitaxel-eluting stent (PES) with respect to long-term individual clinical outcomes...
  52. doi request reprint Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy
    Amar Narula
    NYU Langone Medical Center, New York, NY, USA
    Eur Heart J 35:1533-40. 2014
    ..5 mg/dL or a 25% relative rise within 48 h after contrast exposure) from the large-scale HORIZONS-AMI trial...
  53. doi request reprint Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI]
    Eugenia Nikolsky
    Department of Cardiology, Rambam Health Care Campus and the Technion Israel Institute of Technology, Haifa, Israel
    Am J Cardiol 111:1377-86. 2013
    ..19). In the HORIZONS-AMI trial, previous CABG was associated with a delay to mechanical reperfusion and lower rates of percutaneous coronary intervention and patency of the infarct related vessel along with worse clinical outcomes...
  54. doi request reprint Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial
    Bimmer E Claessen
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Eur Heart J 33:768-75. 2012
    ....
  55. doi request reprint Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS
    Diaa A Hakim
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    Am Heart J 161:391-6. 2011
    ..Thrombocytopenia (TP) is a common abnormality in patients presenting with acute coronary syndrome. Whether baseline TP has any influence on the outcome of patients treated with primary angioplasty for acute myocardial infarction is unknown...
  56. doi request reprint Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic rena
    Roxana Mehran
    Center for Interventional Vascular Therapies, Columbia University Medical Center, New York, New York 10032, USA
    JACC Cardiovasc Interv 2:415-21. 2009
    ....
  57. doi request reprint Quantitative angiographic characterization of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention
    Kleanthis Theodoropoulos
    Icahn School of Medicine at Mount Sinai, New York, NY, USA
    EuroIntervention . 2016
    ..We sought to assess and describe the angiographic features and burden of CAD in patients with HIV as compared to those without HIV infection...
  58. doi request reprint Cerebrovascular events after a primary percutaneous coronary intervention strategy for acute ST-segment-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial
    Eugenia Nikolsky
    From the Cardiology Department, Rambam Health Care Campus and the Technion Israel Institute of Technology, Haifa, Israel E N Cardiovascular Research Foundation, New York, NY R M, G D D, K X, R P, P G, S J B, G W S Icahn School of Medicine at Mount Sinai, New York, NY R M, G D D Helios Amper Klinikum, Dachau, Germany B W Ospedale Papa Giovanni XXIII, Bergamo, Italy G G Rabin Medical Center, Petach Tikva, Israel R K Hôpital du Sacré Coeur de Montréal, Quebec, Canada P G Columbia University Medical Center, New York, NY P G, G W S and New York Methodist Hospital, Brooklyn S J B
    Circ Cardiovasc Interv 8:. 2015
    ..We assessed the incidence, predictors, and implications of cerebrovascular events in patients with ST-segment-elevation myocardial infarction managed with a primary percutaneous coronary intervention strategy...
  59. doi request reprint Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention
    Ajay J Kirtane
    From Herbert and Sandi Feinberg Interventional Cardiology and Heart Valve Center, Columbia University Medical Center New York Presbyterian Hospital, New York, NY A J K, D D, M B L, D K, M A P, G W S, J W M Cardiovascular Research Foundation, New York, NY A J K, D D, M B L, D K, M A P, G W S, J W M Washington University in St Louis, St Louis, MO J M L The Program for Advanced Coronary Disease, Duke University Medical Center, Durham, NC E M O Henry Ford Hospital, Detroit, MI W W O University of Illinois, Chicago A S University of Miami Miller School of Medicine, Miami, FL M G C Massachusetts General Hospital, Harvard Medical School, Boston I F P Mount Sinai Medical Center, Miami, FL N B University of Chicago, Chicago, IL N U Tufts Medical Center, Boston, MA N K K University of Washington Medical Center, Seattle W L and Mount Sinai Medical Center, New York, Germany
    Circulation 134:422-31. 2016
    ..Ultimately, an evolution of contemporary interventional cardiology is necessary to treat the increasingly higher-risk patients with whom we are confronted...
  60. doi request reprint Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies
    Ziad Sergie
    Mount Sinai School of Medicine, New York, NY, USA
    J Thromb Thrombolysis 35:483-93. 2013
    ..Finally, we will describe an ongoing large multicenter multinational trial that compares intravenous bivalirudin to unfractionated heparin during TAVR procedures using standardized clinical endpoints...
  61. ncbi request reprint Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts
    Koichi Sano
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 97:1463-6. 2006
    ..These IVUS differences may account for some of the location-specific differences in interventional complications...
  62. ncbi request reprint Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft
    Alexandra J Lansky
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:370-4. 2006
    ..The CSG may be a reliable and highly effective treatment option for sealing coronary perforations complicating percutaneous coronary interventions...
  63. ncbi request reprint Assessing intermediate left main coronary lesions using intravascular ultrasound
    Koichi Sano
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, USA
    Am Heart J 154:983-8. 2007
    ..We aimed to evaluate the severity of ambiguous LMCSs by intravascular ultrasound (IVUS) and to clarify how frequently significant stenosis occurs in the "real world"...
  64. doi request reprint Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus
    Bimmer E Claessen
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 108:924-31. 2011
    ..The use of DES rather than BMS was associated with a reduction in target vessel revascularization in patients with and without DM...
  65. pmc Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
    Roxana Mehran
    Columbia University Medical Center and Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, USA
    Eur Heart J 30:1457-66. 2009
    ..Both MI and major bleeding predict 1-year mortality in patients presenting with acute coronary syndrome (ACS). However, the risk of each of these events on the magnitude and timing of mortality has not been well studied...
  66. ncbi request reprint Safety issues related to treating bifurcation lesions
    Adam J Saltzman
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Rev Cardiovasc Med 11:S3-10. 2010
    ..Assessment of lesions both before and after stenting using intravascular ultrasound in addition to quantitative coronary angiography may result in fewer complications...
  67. doi request reprint Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials
    Gennaro Giustino
    The Zena and Michael A Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York
    J Am Coll Cardiol 65:1298-310. 2015
    ..The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation is unclear, and its risks and benefits may vary according to DES generation...
  68. doi request reprint Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST-segment elevation myocardial infarction: results of the HORIZONS-AMI trial
    Alejandra Guerchicoff
    Cardiovascular Research Foundation, New York, New York
    Catheter Cardiovasc Interv 85:335-42. 2015
    ..Contrast-induced acute kidney injury (CI-AKI) may occur after percutaneous coronary intervention (PCI)...
  69. ncbi request reprint Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation
    Hideo Takebayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    Circulation 110:3430-4. 2004
    ..Little is known about causes of intimal hyperplasia (IH) after sirolimus-eluting stent (SES) implantation...
  70. doi request reprint Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial
    Adriano Caixeta
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10029, USA
    J Thromb Thrombolysis 31:154-64. 2011
    ..Baseline CRP level is a powerful independent predictor of both early and late mortality in patients with ACS being treated with an early invasive strategy, especially in troponin positive patients...
  71. ncbi request reprint Minimally invasive coronary artery bypass grafting versus stenting for patients with proximal left anterior descending coronary artery disease
    Kazuyuki Shirai
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 93:959-62. 2004
    ..For nondiabetics with proximal LAD disease, stenting may be the revascularization strategy of choice...
  72. doi request reprint Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials
    Usman Baber
    Mount Sinai School of Medicine, Zena and Michael A Weiner Cardiovascular Institute, 1190 Fifth Avenue 1 South, New York, NY 10029, USA
    J Am Coll Cardiol 58:1569-77. 2011
    ....
  73. doi request reprint Angioscopic and virtual histology intravascular ultrasound characteristics of culprit lesion morphology underlying coronary artery thrombosis
    Elias A Sanidas
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 107:1285-90. 2011
    ....
  74. doi request reprint Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZO
    Eugenia Nikolsky
    Rambam Health Care Campus and Technion Israel Institute of Technology, Haifa, Israel
    Am J Cardiol 109:831-8. 2012
    ..The risk of adding oral anticoagulation to patients admitted for STEMI should be carefully considered before choosing drug-eluting or bare metal stents...
  75. ncbi request reprint Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Semin Thromb Hemost 30:305-14. 2004
    ..Optimal dosing regimens for argatroban, lepirudin, and bivalirudin should be further established in PCI patients...
  76. doi request reprint Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomes
    Georgios Christodoulidis
    The Icahn School of Medicine at Mount Sinai, New York, NY
    Am Heart J 170:180-6. 2015
    ..However, the significance of gender in outcomes following BAV remains controversial...
  77. doi request reprint Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty
    Annapoorna Kini
    Mount Sinai Medical Center, New York, NY, USA
    EuroIntervention 10:312-9. 2014
    ..We sought to assess if bivalirudin use during balloon aortic valvuloplasty (BAV) would affect clinical outcomes compared with heparin...
  78. doi request reprint Clinical outcome of nonculprit plaque ruptures in patients with acute coronary syndrome in the PROSPECT study
    Yong Xie
    Division of Cardiology, Columbia University Medical Center, New York, New York Clinical Trials Center, Cardiovascular Research Foundation, New York, New York Department of Cardiology, Northern Jiangsu People s Hospital, Yangzhou University, Yangzhou, China
    JACC Cardiovasc Imaging 7:397-405. 2014
    ....
  79. ncbi request reprint Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions
    Eugenia Nikolsky
    Cardiovascular Research Foundation and the Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Endovasc Ther 11:60-70. 2004
    ..To determine the impact of symptomatic peripheral arterial disease (PAD) on clinical outcomes in patients treated with percutaneous coronary interventions (PCI)...
  80. ncbi request reprint Gender-specific outcomes after sirolimus-eluting stent implantation
    Emilia Solinas
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 50:2111-6. 2007
    ..We examined the impact of gender on outcomes of patients undergoing percutaneous coronary intervention using sirolimus-eluting stents (SES)...
  81. pmc Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study
    George D Dangas
    Cardiovascular Research Foundation, New York, NY, USA
    Eur Heart J Cardiovasc Imaging 15:201-9. 2014
    ....
  82. ncbi request reprint Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems
    Bimmer E Claessen
    Cardiovascular Research Foundation, New York, NY, USA
    Curr Pharm Des 16:4012-24. 2010
    ..This review article focusses on the clinical studies that have been performed with DES eluting Sirolimus or its analogues...
  83. ncbi request reprint Bolus-only glycoprotein IIb/IIIa inhibitor revisited
    Abdolreza Agahtehrani
    Columbia University Medical Center, 161 Fort Washington Avenue, 5th Floor, New York, NY 10032, USA
    J Invasive Cardiol 18:527. 2006